These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
380 related articles for article (PubMed ID: 23069705)
1. Detection of Ro/SS-A antibodies in lupus erythematosus: what does it mean for the dermatologist? Böckle BC; Stanarevic G; Sepp NT J Am Acad Dermatol; 2013 Mar; 68(3):385-94. PubMed ID: 23069705 [TBL] [Abstract][Full Text] [Related]
2. Cutaneous lupus erythematosus: first multicenter database analysis of 1002 patients from the European Society of Cutaneous Lupus Erythematosus (EUSCLE). Biazar C; Sigges J; Patsinakidis N; Ruland V; Amler S; Bonsmann G; Kuhn A; Autoimmun Rev; 2013 Jan; 12(3):444-54. PubMed ID: 23000206 [TBL] [Abstract][Full Text] [Related]
3. The use of antibody to C5b-9 in the subclassification of lupus erythematosus. Magro CM; Crowson AN; Harrist TJ Br J Dermatol; 1996 May; 134(5):855-62. PubMed ID: 8736325 [TBL] [Abstract][Full Text] [Related]
4. The relationship between anti-Ro (SS-A) antibody-positive Sjögren's syndrome and anti-Ro (SS-A) antibody-positive lupus erythematosus. Provost TT; Talal N; Harley JB; Reichlin M; Alexander E Arch Dermatol; 1988 Jan; 124(1):63-71. PubMed ID: 3257371 [TBL] [Abstract][Full Text] [Related]
5. Clinical manifestations of cutaneous lupus erythematosus. Kuhn A; Sticherling M; Bonsmann G J Dtsch Dermatol Ges; 2007 Dec; 5(12):1124-37. PubMed ID: 18042093 [TBL] [Abstract][Full Text] [Related]
6. Subacute cutaneous lupus erythematosus versus systemic lupus erythematosus: diagnostic criteria and therapeutic implications. Chlebus E; Wolska H; Blaszczyk M; Jablonska S J Am Acad Dermatol; 1998 Mar; 38(3):405-12. PubMed ID: 9520021 [TBL] [Abstract][Full Text] [Related]
7. The classification and diagnosis of cutaneous lupus erythematosus. Kuhn A; Landmann A J Autoimmun; 2014; 48-49():14-9. PubMed ID: 24486120 [TBL] [Abstract][Full Text] [Related]
8. Epidemiological characteristics of patients with cutaneous lupus erythematosus. Avilés Izquierdo JA; Cano Martínez N; Lázaro Ochaita P Actas Dermosifiliogr; 2014; 105(1):69-73. PubMed ID: 24268922 [TBL] [Abstract][Full Text] [Related]
9. The different faces of cutaneous lupus erythematosus. Renner R; Sticherling M G Ital Dermatol Venereol; 2009 Apr; 144(2):135-47. PubMed ID: 19357621 [TBL] [Abstract][Full Text] [Related]
12. [Overlap of Sjögren-lupus erythematosus syndrome]. Trüeb RM; Borelli S; Schmid-Grendelmeier P; Panizzon RG; Burg G Hautarzt; 1995 Jul; 46(7):467-71. PubMed ID: 7672985 [TBL] [Abstract][Full Text] [Related]
13. Analysis of 303 Ro/SS-A antibody-positive patients: is this antibody a possible marker for malignancy? Böckle BC; Stanarevic G; Ratzinger G; Sepp NT Br J Dermatol; 2012 Nov; 167(5):1067-75. PubMed ID: 22816490 [TBL] [Abstract][Full Text] [Related]
14. [Subacute cutaneous lupus erythematosus: clinical aspects, immunology and therapy]. Ruzicka T; Bieber T; Meurer M Wien Klin Wochenschr; 1987 Dec; 99(23):802-7. PubMed ID: 3324494 [TBL] [Abstract][Full Text] [Related]
15. Estradiol enhances binding to cultured human keratinocytes of antibodies specific for SS-A/Ro and SS-B/La. Another possible mechanism for estradiol influence of lupus erythematosus. Furukawa F; Lyons MB; Lee LA; Coulter SN; Norris DA J Immunol; 1988 Sep; 141(5):1480-8. PubMed ID: 2457617 [TBL] [Abstract][Full Text] [Related]